IP Library Assignment 053307/0218
Patent Assignment
Reel/Frame 053307/0218

Assignment of Assignor's Interest

Recorded: 2020-07-24 Pages: 3
Assignors
GUERRY, PHILIPPE
Executed: 2020-07-23
VON RAUMER, MARKUS
Executed: 2020-07-22
Assignee
IDORSIA PHARMACEUTICALS LTD.
HEGENHEIMERMATTWEG 91, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Property (1)
Crystalline Forms of the CXCR7 Receptor Antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-Difluoro-Phenyl)-Isoxazole-3-Carbonyl]-Amino}-Piperidine-3-Carboxylic Acid (1-Pyrimidin-2-Yl-Cyclopropyl)-Amide
Application: 16/964,885 →
Publication: US 2021/0115033
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →